This doesn’t apply to people arriving from Andorra, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chinese Taipei, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, Ireland (Rep.), Italy, Jordan, Korea (Rep.), Latvia, Liechtenstein, Lithuania, Luxembourg, Macao, Malta, Moldova (Rep.), Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Qatar, Romania, San Marino, Saudi Arabia, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, Uruguay, Vatican City (Holy See) or Viet Nam with:

• a negative COVID-19 antigen test result issued not more than 24 hours before arrival which is for personal use and recorded in an official data processing system; or
• a negative COVID-19 antigen test result issued not more than 48 hours before arrival; or
• a negative COVID-19 LAMP, PCR or TMA test result issued not more than 72 hours before arrival; or
• a COVID-19 recovery certificate issued not more than 180 days before arrival; or
• proof of the presence of COVID-19 antibodies issued not more than 90 days before arrival; or
• a COVID-19 vaccination certificate stating that they received:
• the second vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at most 360 days before arrival. A combination of vaccines is accepted; or
• the third vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 120 days after the second dose and at most 360 days before arrival; or
• the Janssen vaccine at least 22 days and at most 270 days before arrival; or
• the second vaccine dose of Janssen vaccine at least 120 days after the first dose and at most 360 days before arrival; or
• the first vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 22 days and at most 360 days before arrival and proof of previous COVID-19 infection; or
• the second vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac, at least 120 days after the first dose and at most 360 days before arrival and proof of previous COVID-19 infection.

People arriving from Cyprus must:

• have a negative COVID-19 LAMP, PCR or TMA test result issued not more than 72 hours before arrival; or
• take a COVID-19 LAMP, PCR or TMA test upon arrival; or
• have a COVID-19 vaccination certificate showing that they received:
• the second vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at most 360 days before arrival. A combination of vaccines is accepted; or
• the third vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 120 days after the second dose and at most 360 days before arrival; or
• the Janssen vaccine at least 22 days and at most 270 days before arrival; or
• the second vaccine dose of Janssen vaccine at least 120 days after the first dose and at most 360 days before arrival; or
• the first vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 22 days and at most 360 days before arrival and proof of previous COVID-19 infection; or
• the second vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac, at least 120 days after the first dose and at most 360 days before arrival and proof of previous COVID-19 infection.

This does not apply to:

• children under 12 if accompanied by an adult;
• people who have been in Brazil, Chile, Costa Rica or Suriname in the past 10 days.

Those who arrive from or have been in Brazil, Chile, Costa Rica or Suriname in the past 10 days:

• must have a negative COVID-19 LAMP, PCR or TMA test result issued not more than 72 hours before arrival;
• are subject to quarantine for 10 days.

The COVID-19 test requirement doesn’t apply to children under 12 if accompanied by an adult.

Arriving people could be subject to self-quarantine for 10 days.

This doesn’t apply to:

• children between 12 and 18 travelling with their vaccinated parents/guardians; or
• holders of a COVID-19 recovery certificate issued not more than 180 before arrival; or
• holders of proof of the presence of COVID-19 antibodies issued not more than 90 days before arrival; or
• holders of a COVID-19 vaccination certificate stating that they received:
• the second vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at most 360 days before arrival. A combination of vaccines is accepted; or
• the third vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 120 days after the second dose and at most 360 days before arrival; or
• the Janssen vaccine at least 22 days and at most 270 days before arrival; or
• the second vaccine dose of Janssen vaccine at least 120 days after the first dose and at most 360 days before arrival; or
• the first vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 22 days and at most 360 days before arrival and proof of previous COVID-19 infection; or
• the second vaccine dose of AstraZeneca (Vaxzevria), Covishield, Moderna, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac, at least 120 days after the first dose and at most 360 days before arrival and proof of previous COVID-19 infection.

More information can be found here